drugset / Trial / NCT04736745
Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines.
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of the protocol, is to assess the safety and efficacy profile of IPN59011 compared to a placebo. IPN59011 is expected to work longer than product already marketed in the treatment of subjects with moderate to severe facial wrinkles.
Timeline
- Start
- 2021-02-10
- Primary completion
- 2022-10-28
- Completion
- 2022-10-28
Outcome
Outcome not reported
Stopped (Business): “Sponsor terminated the study due to strategic considerations”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azzalure | Protein / enzyme biologic | — | Other |
| Subject | IPN59011 | Unknown | — | Other |
Indications
No indication recorded.